Abera Bioscience AB
ABERA | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0015245097
- LEI:
- 549300IO3Q8IE2FDUS29
- Country:
- Sweden
- Address:
- BOX 1747, 751 47 Uppsala
- Website:
- https://aberabio.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Abera Bioscience AB is a biotechnology company developing next-generation mucosal vaccines based on its proprietary vaccine delivery platform, BERA. This novel platform utilizes Outer Membrane Vesicles (OMVs) that can be decorated with large amounts of one or more antigens, enabling the creation of efficient multivalent vaccines that elicit a strong and broad protective immune response. Abera's pipeline focuses on vaccine candidates for mucosal administration, such as nasal sprays, to address significant infectious disease challenges. The company's lead candidate is a universal pneumococcal vaccine (Ab-01.12) advancing towards clinical trials. Additionally, Abera is active in pandemic preparedness, developing technologies like a nasal influenza vaccine candidate.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Abera Bioscience AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Abera Bioscience AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Abera Bioscience AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
